Cardiac Valve Repair Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Cardiac Valve Repair Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Summary
GlobalData's Medical Devices sector report, “Cardiac Valve Repair Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Cardiac Valve Repair Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Cardiac valve repair devices are used in the Open-Heart surgery to repair the malfunctioning of valves.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Cardiac Valve Repair Devices under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Cardiac Valve Repair Devices and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Cardiac Valve Repair Devices under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
About GlobalData
Introduction
Cardiac Valve Repair Devices Overview
Products under Development
Cardiac Valve Repair Devices - Pipeline Products by Stage of Development
Table Figure 1: Cardiac Valve Repair Devices - Pipeline Products by Stage of Development
Table Cardiac Valve Repair Devices - Pipeline Products by Stage of Development
Cardiac Valve Repair Devices - Pipeline Products by Segment
Table AccuCinch Ventricular Restoration System - Product Status
Table AccuCinch Ventricular Restoration System - Product Description
Table Ancora Heart Inc - Ongoing Clinical Trials Overview
Table AccuCinch Ventricular Restoration System - Randomized Clinical Evaluation of the AccuCinch Ventricular Restoration System in Patients who Present with Symptomatic Heart Failure with Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study
Table AccuCinch Ventricular Restoration System - Safety and Performance Evaluation of the AccuCinch Ventricular Repair System for Functional Mitral Regurgitation Due to Dilated Ischemic or Non-Ischemic Cardiomyopathy - The CorCinch-EU Study
Table Revivent-TC System - Clinical Study of the BioVentrix Revivent TC System for Treatment of Left Ventricular Aneurysms ALIVE-EA (American Less Invasive Ventricular Enhancement-Expanded Access)
Table Revivent-TC System - Clinical Study of the BioVentrix Revivent TC System for Treatment of Left Ventricular Aneurysms: ALIVE
Table Revivent-TC System - Randomized Evaluation and Verification of Ventricular Enhancement: The REVIVE-HF Study
Boston Children's Hospital Company Overview
Boston Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview
Table DaVingiTR System - Early Feasibility Study (EFS) of the Cardiac Implants Percutaneous Ring Annuloplasty System for the Treatment of Functional Tricuspid Regurgitation
Table PASCAL Transcatheter Tricuspid Valve Repair System - A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Tricuspid Valve Repair with the Edwards PASCAL Transcatheter Valve Repair System and Optimal Medical Therapy (OMT) Compared to OMT Alone in Patients with Tricuspid Regurgitation
Table PASCAL Transcatheter Tricuspid Valve Repair System - Edwards PASCAL Transcatheter Valve Repair System Registry: A Multicenter Observational Registry with the Edwards PASCAL Transcatheter Valve Repair System
Table PASCAL Transcatheter Tricuspid Valve Repair System - Evaluation of the Safety, Efficacy and Cost-effectiveness of Transcatheter Tricuspid Valve Repair in Patients With Severe Tricuspid Regurgitation in the Netherlands.
Table PASCAL Transcatheter Tricuspid Valve Repair System - PASTE: PASCAL for Tricuspid Regurgitation - A European Registry
Table PASCAL Transcatheter Tricuspid Valve Repair System - Transcatheter Repair of Tricuspid Regurgitation with Edwards PASCAL Transcatheter Valve Repair System: A European Prospective, Multicenter Post-market Clinical Follow up
Emory University Company Overview
Emory University Pipeline Products & Ongoing Clinical Trials Overview
Table Emory University Pipeline Products & Ongoing Clinical Trials Overview
Table MitraSurg - Product Status
Table MitraSurg - Product Description
Georgia Institute of Technology Company Overview
Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
Table Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
Table Tricuspid Annuloplasty Ring - Product Status
Table Tricuspid Annuloplasty Ring - Product Description
Hanxin Medical Technology (Shenzhen) Co Ltd Company Overview
Hanxin Medical Technology (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table Hanxin Medical Technology (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table Mitral Valve Tendon Repair System - Product Status
Table Mitral Valve Tendon Repair System - Product Description
Table Hanxin Medical Technology (Shenzhen) Co Ltd - Ongoing Clinical Trials Overview
Table Mitral Valve Tendon Repair System - A Prospective, Multicentre, Single-arm Clinical Trial to Evaluate the Safety and Efficacy of an Interventional Mitral Chordae Tendineae Repair System for the Treatment of Mitral Regurgitation
Table Mitral Valve Tendon Repair System - Clinical Trial to Evaluate the Safety and Efficacy of an Interventional Mitral Valve Tendon Repair System for the Treatment of Mitral Regurgitation - People's Hospital of Gaozhou
Table Mitral Valve Tendon Repair System - Clinical Trial to Evaluate the Safety and Efficacy of an Interventional Mitral Valve Tendon Repair System for the Treatment of Mitral Regurgitation - Guangdong Provincial People's Hospital
Harpoon Medical Inc Company Overview
Harpoon Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table Harpoon Medical Inc - Ongoing Clinical Trials Overview
Table HARPOON Beating Heart Mitral Valve Repair System - A Prospective, Multi-center Trial to Evaluate the Safety and Effectiveness of Beating Heart Mitral Valve Repair with the HARPOON System (RESTORE)
HVR Cardio Oy Company Overview
HVR Cardio Oy Pipeline Products & Ongoing Clinical Trials Overview
Table Edwards Cardioband Mitral Reconstruction System - European Registry of Transcatheter Repair for Secondary Mitral Regurgitation
Table Edwards Cardioband Mitral Reconstruction System - Transcatheter Repair of Mitral Regurgitation with Cardioband System Post Market Study: A European Prospective, Multicenter Study to Assess Transcatheter Mitral Valve Repair with Edwards Cardioband System in Patients with Symptomatic MR
Apr 22, 2024: Genesee BioMedical Receives FDA 510(k) Clearance for TransForm McCarthy Mitral Annuloplasty Ring (TF)
Apr 17, 2024: Annoviant wins $2.9m NIH grant for paediatric heart conduits
Apr 15, 2024: Edwards Lifesciences Appoints New China Head
Apr 08, 2024: Cardiology Team Performs Novel Heart Valve Repair with Newly Approved Device
Mar 29, 2024: MicroPort CardioFlow Medtech Full Year 2023 Earnings
Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference
Feb 23, 2024: Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference
Feb 22, 2024: NeoChord Appoints New Chief Executive Officer to Lead Commercialization Efforts and Study Novel First-Line Therapy for Mitral Valve Regurgitation
Feb 16, 2024: Jim Robo, Former Chairman and CEO of NextEra Energy, to Join Mayo Clinic Board of Trustees
Feb 14, 2024: AMC Professor Joon Bum Kim invited to lecture at Stanford Medicine, USA
Jan 15, 2024: Affluent Medical : Pre-submission Dossier for the 510(K) of Medical Device Kaliostm Filed With FDA for Review
Oct 18, 2023: Edwards Lifesciences to Host Earnings Conference Call on October 25, 2023
Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business
Sep 13, 2023: Affluent Medical announces positive clinical results and further insights to enhance its strategy on Structural Heart activities
Aug 29, 2023: MicroPort CardioFlow Medtech Corp. Announces Change of Directors and Chairman
Aug 29, 2023: Microport Cardioflow Medtech Announces Change of Directors and Chairman
Aug 28, 2023: Edwards Lifesciences to Present at the 2023 Wells Fargo Healthcare Conference
Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair
Aug 24, 2023: CollPlant Biotechnologies Announces Second Quarter Financial Results For 2023 with Revenues of $10.2 Million
Aug 17, 2023: Mayo Clinic Reports Strong Finances for 2023 So Far with Q2 Revenue of $4.47 billion
Aug 11, 2023: Kristin Peck, CEO of Zoetis, to join Mayo Clinic Board of Trustees
Aug 09, 2023: Collplant Biotechnologies Announces Date for 2023 Second Quarter Financial Results and Conference Call Information
Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024
Jun 15, 2023: Genesee BioMedical Receives 510(k) Clearance for WellsForm Tricuspid Annuloplasty Band (WF)
May 24, 2023: CollPlant Biotechnologies announces first quarter financial results for 2023 and provides corporate update
May 23, 2023: Study: Transcatheter Mitral Valve Repair Safe, Successful